Spectrum Pharmaceuticals

Spectrum Pharmaceuticals Current Assets

Delisted

The Current Assets of Spectrum Pharmaceuticals (SPPI) as of Nov 15, 2026 is 101.01 M USD. In the previous year, Current Assets was 103.95 M USD — a change of -2.83% (lower).

Current Assets

101.01 MUSD

YoY

-2.83%

Last updated:

Current Assets of Spectrum Pharmaceuticals is 2022 101.01 M USD. Current Assets of Spectrum Pharmaceuticals was 2021 103.95 M USD. It decreases by -2.83% lower compared to the previous year.

The Spectrum Pharmaceuticals Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2015
191.37 M USD
Jan 1, 2016
216.61 M USD
Jan 1, 2017
269.57 M USD
Jan 1, 2018
241.75 M USD
Jan 1, 2019
244.02 M USD
Jan 1, 2020
186.69 M USD
Jan 1, 2021
103.95 M USD
Jan 1, 2022
101.01 M USD
The Spectrum Pharmaceuticals Current Assets history
YEARCurrent AssetsYoY
101.01 MUSD-2.83%
103.95 MUSD-44.32%
186.69 MUSD-23.50%
244.02 MUSD+0.94%
241.75 MUSD-10.32%
269.57 MUSD+24.45%
216.61 MUSD+13.19%
191.37 MUSD-13.96%
222.42 MUSD-5.42%
235.17 MUSD-11.23%
264.90 MUSD+17.32%
225.80 MUSD+85.21%
121.91 MUSD-48.91%
238.61 MUSD+163.89%
90.42 MUSD+59.69%
56.62 MUSD+8.19%
52.34 MUSD-18.73%
64.40 MUSD+60.99%
40.00 MUSD+49.55%
26.75 MUSD+1,029.77%
2.37 MUSD-68.61%
7.54 MUSD-36.55%
11.89 MUSD+21.16%
9.81 MUSD+197.32%
3.30 MUSD-64.52%
9.30 MUSD-41.51%
15.90 MUSD—
0.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Spectrum Pharmaceuticals Stock analysis

What does Spectrum Pharmaceuticals do? Spectrum Pharmaceuticals Inc. is an American biotechnology company specializing in the development and commercialization of drugs for the treatment of cancer and other serious diseases. It was founded in 1987 and is headquartered in Irvine, California. The company's CEO is Rajesh C. Shrotriya, who has a clear vision of specializing in pharmaceutical development to meet the needs of patients with unmet medical needs. Spectrum Pharmaceuticals has a wide range of products, with a focus on oncology and hematology. It also has a promising drug candidate pipeline. The company works closely with healthcare professionals and regulatory authorities to ensure the highest quality standards are met. Spectrum Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Spectrum Pharmaceuticals stock

Current Assets of Spectrum Pharmaceuticals is 101.01 M USD in 2022.

Current Assets of Spectrum Pharmaceuticals changed from 103.95 M USD to 101.01 M USD, representing a -2.83% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Spectrum Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Spectrum Pharmaceuticals historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Spectrum Pharmaceuticals

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Spectrum Pharmaceuticals